EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC 4.0

Hemostatic and liver function parameters as COVID-19 severity markers

Qanita Iqbal, Mudatsir Mudatsir, Harapan Harapan, Nurjannah Nurjannah, Teuku Maulana

Narra J · 2024

DOI: 10.52225/narra.v4i1.178 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Narra J, 2024. Verfasst von Qanita Iqbal und 4 weiteren Autor:innen. Beteiligte Einrichtung: Master Program of Public Health, Faculty of Medicine, Universitas Syiah Kuala, Banda Aceh, Indonesia. Hauptthemen laut MEDLINE: COVID-19, Severity of Illness Index, Biomarkers. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a disease newly discovered in December 2019 which affects coagulation cascade and liver functions. The aim of this study was to investigate the potential of hemostatic and liver function parameters as severity markers in COVID-19 patients. This study was an observational analytic with cohort retrospective design using total sampling method. Data were retrieved from medical record of COVID-19 patients admitted to provincial hospital in Banda Aceh, Indonesia from March 2020 to March 2022. There were 1208 data eligible for the study after applying certain criteria. Mann–Whitney, logistic regression, and receiving operating characteristic (ROC) analyses were used to analysis the data. Thrombocyte count (p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Severity of Illness IndexBiomarkersHumansMaleFemaleRetrospective StudiesMiddle AgedAdultLiver Function TestsFibrin Fibrinogen Degradation ProductsIndonesiaSARS-CoV-2FibrinogenAspartate AminotransferasesHemostasisAgedPlatelet CountLiverAlanine Transaminase

Stichwörter der Autor:innen

COVID-19hemostaticliver functionmortalityseverity

Substanzen

BiomarkersFibrin Fibrinogen Degradation Productsfibrin fragment DFibrinogenAspartate AminotransferasesAlanine Transaminase

Autor:innen und Institutionen

  • Master Program of Public Health, Faculty of Medicine, Universitas Syiah Kuala, Banda Aceh, Indonesia.
  • Medical Research Unit, School of Medicine, Universitas Syiah Kuala, Banda Aceh, Indonesia.
  • Tropical Disease Centre, School of Medicine, Universitas Syiah Kuala, Banda Aceh, Indonesia.
  • Department of Microbiology, School of Medicine, Universitas Syiah Kuala, Banda Aceh, Indonesia.
  • Tsunami and Disaster Mitigation Research Center, Universitas Syiah Kuala, Banda Aceh, Indonesia.
  • Department of Public Health, Faculty of Medicine, Universitas Syiah Kuala, Banda Aceh, Indonesia.

Zitieren

APA

Iqbal, Q., Mudatsir, M., Harapan, H., Nurjannah, N., & Maulana, T. (2024). Hemostatic and liver function parameters as COVID-19 severity markers. Narra J. https://doi.org/10.52225/narra.v4i1.178

Vancouver

Iqbal Q, Mudatsir M, Harapan H, Nurjannah N, Maulana T. Hemostatic and liver function parameters as COVID-19 severity markers. Narra J. 2024. doi:10.52225/narra.v4i1.178

BibTeX
@article{Iqbal2024,
  author = {Iqbal, Qanita and Mudatsir, Mudatsir and Harapan, Harapan and Nurjannah, Nurjannah and Maulana, Teuku},
  title = {Hemostatic and liver function parameters as COVID-19 severity markers},
  journal = {Narra J},
  year = {2024},
  doi = {10.52225/narra.v4i1.178}
}
Kostenlos starten →